Logroscino G, Urso D, Gnoni V, Giugno A, Vilella D, Castri A, Barone R, Nigro S, Zecca C, De Blasi R, Introna A. Mild cognitive impairment and early Alzheimer's disease eligibility for disease modification therapies in a tertiary centre for cognitive disorders: A simultaneous real-word study on aducanumab and lecanemab. Eur J Neurol. 2025 Jan;32(1):e16534. Epub 2024 Nov 5 PubMed.
Recommends
Please login to recommend the paper.
Comments
No Available Comments
Make a Comment
To make a comment you must login or register.